Key Takeaways
- Placenta previa affects approximately 1 in 200 pregnancies at term
- The incidence of placenta previa is about 0.5% in singleton pregnancies
- Placental previa prevalence increases with maternal age over 40 to 2-3%
- Smoking increases placenta previa risk by 1.5-2 fold
- Prior cesarean section raises risk to 1.5% per prior CS
- Advanced maternal age >35 years doubles the risk (OR 2.2)
- The most common symptom is painless vaginal bleeding in third trimester (80%)
- Ultrasound diagnosis: placenta covering internal os seen in 100% transvaginal US
- 90% of placenta previa diagnosed before 20 weeks resolve by term
- Maternal mortality from placenta previa is 0.03-0.1%
- Postpartum hemorrhage occurs in 22-51% of cases
- Hysterectomy rate 5-10% in placenta previa, higher if accreta
- Preterm delivery <37 weeks in 70-80% of placenta previa cases
- Perinatal mortality 1-4 per 1000 in modern settings
- Fetal growth restriction in 10-15%
Placenta previa causes painless bleeding and usually requires an early cesarean delivery.
Clinical Presentation
- The most common symptom is painless vaginal bleeding in third trimester (80%)
- Ultrasound diagnosis: placenta covering internal os seen in 100% transvaginal US
- 90% of placenta previa diagnosed before 20 weeks resolve by term
- Bleeding occurs in 70-80% of cases
- Transvaginal ultrasound sensitivity 87-99% for diagnosis
- No bleeding in 20-30% until labor
- Uterine contractions precede bleeding in 30% of symptomatic cases
- MRI used in 10-15% for equivocal US cases
- Placenta previa causes 20% of third-trimester bleeding
- Severe hemorrhage requiring transfusion in 10-20% at presentation
- Vaginal bleeding at 28-32 weeks in 40%
- Color Doppler US specificity 98% for vasa previa exclusion
- Supine hypotension symptom in 15%
- 3D US improves diagnosis accuracy to 99%
- Fetal malpresentation 35%
- Silent previa 10-20%
- TVUS measures os distance <2cm diagnostic
- Breech 40% at diagnosis
- Polyhydramnios 12%
- Spotting only 25% presentations
- Ultrasound screening detects 100% at 18-20w anatomy scan
Clinical Presentation Interpretation
Complications
- Placental abruption co-occurs in 10-20%
- Emergency cesarean rate 70-100% in bleeding cases
- Recurrence risk 4-8% in future pregnancies
- Classical CS incision risk with previa 10x higher abruption
- DIC risk 1-3%
- Uterine rupture rare 0.5%
- Bladder invasion in 5% previa-accreta
- Infection rate post-CS 15%
- Vena cava syndrome 5%
- Wound dehiscence 8%
- Cord prolapse 4%
- Endometritis 12%
Complications Interpretation
Epidemiology
- Placenta previa affects approximately 1 in 200 pregnancies at term
- The incidence of placenta previa is about 0.5% in singleton pregnancies
- Placental previa prevalence increases with maternal age over 40 to 2-3%
- In the US, placenta previa occurs in 4.4 per 1000 deliveries
- Globally, placenta previa incidence is 0.3-0.5% of pregnancies
- Placenta previa rates rose from 0.26% in 1990 to 0.41% in 2010 in the UK
- Among IVF pregnancies, placenta previa incidence is 1.5-2%
- In twin pregnancies, placenta previa occurs in 1.4% of cases
- Placenta previa is found in 3.5% of cesarean deliveries before 36 weeks
- Racial disparity: higher in African American women at 0.6% vs 0.4% in whites
- Placenta previa incidence decreases from 6% at 20 weeks to 0.3% at term
- In multiparous women, rate is 1.7 per 1000 vs 0.9 in primiparous
- Incidence of complete previa 5%, partial 15%, marginal 25%, low-lying 55%
- Placenta previa more common in Asians (OR 1.7)
- Placenta previa in 2.8/1000 primipara vs 4.3/1000 multipara
- Low-lying placenta resolves 90% by 36 weeks
- Placenta previa in 0.4% low-risk pregnancies
Epidemiology Interpretation
Fetal Outcomes
- Preterm delivery <37 weeks in 70-80% of placenta previa cases
- Perinatal mortality 1-4 per 1000 in modern settings
- Fetal growth restriction in 10-15%
- Neonatal respiratory distress syndrome risk increased 3-fold
- Optimal delivery at 36-37 weeks reduces complications by 50%
- NICU admission 50-60% neonates
- IUGR OR 1.9
- Stillbirth rate 1.5%
- Mean gestational age at delivery 35.2 weeks
- Congenital anomalies 2-3% higher
- Apgar <7 at 5min 10%
- SGA infants 16%
- Ventilation required 5-10% neonates
- Meconium aspiration 3%
Fetal Outcomes Interpretation
Management
- Expectant management success in 70% asymptomatic cases
- Cesarean section required in 90-100% of diagnosed cases at term
- Bed rest recommended for stable cases, reduces bleeding episodes by 40%
- Corticosteroids given to 95% for fetal lung maturity <34 weeks
- Magnesium sulfate neuroprotection in 80% preterm deliveries
- Hospitalization from 32 weeks in 60% of cases
- Tocolysis used in 50% to prolong pregnancy >48 hours
- Multidisciplinary team for accreta previa in 100% high-risk cases
- Outpatient management safe in 34% low-risk
- Bethamethasone reduces RDS by 50%
- Delivery timing at 36w0d for anterior previa halves risk
- Prophylactic embolization reduces transfusion 70%
- Antenatal steroids to all <37w, compliance 98%
- Iron supplementation prevents anemia in 60%
- Weekly NST from 32w in 80%
- Cell salvage used in 20% high blood loss cases
- Indomethacin tocolysis effective 65%
- B-Lynch suture in 10% PPH cases
- Delayed cord clamping benefits 70%
Management Interpretation
Maternal Outcomes
- Maternal mortality from placenta previa is 0.03-0.1%
- Postpartum hemorrhage occurs in 22-51% of cases
- Hysterectomy rate 5-10% in placenta previa, higher if accreta
- Blood transfusion needed in 15-40% of deliveries
- Shock in 5% at first bleed
- Maternal ICU admission 2-5%
- Hemoglobin drop >3g/dL in 25% bleeds
- Maternal morbidity index 25%
- Renal failure 1%
- Thromboembolism risk 3x
- Sheehan syndrome rare 0.1%
- Readmission for bleed 15%
Maternal Outcomes Interpretation
Risk Factors
- Smoking increases placenta previa risk by 1.5-2 fold
- Prior cesarean section raises risk to 1.5% per prior CS
- Advanced maternal age >35 years doubles the risk (OR 2.2)
- Multiple gestation increases risk by 2-3 times (OR 2.6)
- IVF conception associated with OR 1.8-6 for placenta previa
- Prior uterine curettage elevates risk (OR 2.3)
- Cocaine use linked to 4-fold increased risk
- Previous placenta previa recurs in 4-8% of subsequent pregnancies
- Nulliparity slightly protective (OR 0.8), but prior deliveries increase risk
- Placenta previa associated with Asherman syndrome (OR 3.5)
- Prior myomectomy increases risk (OR 2.4)
- Endometrial ablation history OR 5.2
- Urban residence OR 1.3
- Obesity BMI>30 OR 0.7 protective?
- Grand multiparity (>5) OR 3.1
- Prior D&E OR 2.9
- Heroin use OR 2.5
- Folic acid deficiency OR 1.4
- Prior LEEP OR 1.6
- Socioeconomic low status OR 1.5
Risk Factors Interpretation
Sources & References
- Reference 1ACOGacog.orgVisit source
- Reference 2NCBIncbi.nlm.nih.govVisit source
- Reference 3PUBMEDpubmed.ncbi.nlm.nih.govVisit source
- Reference 4CDCcdc.govVisit source
- Reference 5WHOwho.intVisit source
- Reference 6OBGYNobgyn.onlinelibrary.wiley.comVisit source
- Reference 7FERTSTERTfertstert.orgVisit source
- Reference 8JAMANETWORKjamanetwork.comVisit source
- Reference 9AJOGajog.orgVisit source
- Reference 10HUMREPRODhumreprod.oxfordjournals.orgVisit source
- Reference 11RADIOLOGYradiology.rsna.orgVisit source
- Reference 12MAYOCLINICmayoclinic.orgVisit source
- Reference 13UPTODATEuptodate.comVisit source
- Reference 14PUBSpubs.rsna.orgVisit source
- Reference 15NEJMnejm.orgVisit source
- Reference 16COCHRANELIBRARYcochranelibrary.comVisit source






